Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
314.4 USD | +0.62% | +1.95% | +9.18% |
01:58pm | HSBC Adjusts Price Target on Amgen to $356 From $322 | MT |
12:53pm | Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.18% | 168B | |
+32.44% | 693B | |
+29.39% | 584B | |
-2.93% | 372B | |
+20.11% | 332B | |
+7.23% | 294B | |
+14.00% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
-0.43% | 162B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen Guides For Full Year 2024 EPS of $19-$20.20 on Revenue of $32.5-$33.8 Billion, vs CIQ Analyst Consensus of $19.53/Share on Revenue of $32.9 Billion